Corresponding Author: Margaret S. Chisolm, MD, Johns Hopkins Bayview Medical Center, 5300 Alpha Commons Dr, Alpha Commons Bldg, Fourth Floor, Baltimore, MD 21224 (mchisol1@jhmi.edu).
Financial Disclosures: Dr Lyketsos reports having received grant support from the National Institute of Mental Health, the National Institute on Aging, the Associated Jewish Federation of Baltimore, the Weinberg Foundation, Forest, GlaxoSmithKline, Eisai, Pfizer, AstraZeneca, Lilly, Ortho-McNeil, Bristol-Myers, and Novartis; having served as a consultant or advisor for AstraZeneca, GlaxoSmithKline, Eisai, Novartis, Forest, Supernus, Adlyfe, Takeda, Wyeth, Lundbeck, Merz, and Lilly; and having received honoraria or travel support from Pfizer, Forest, GlaxoSmithKline, and Health Monitor. No other disclosures were reported.
Additional Contributions: We are grateful to Lawrence Mayer, MD, PhD, Johns Hopkins University School of Medicine and Johns Hopkins University Bloomberg School of Public Health, and David Hellman, MD, Donna Mennitto, MA, and Barbara Verrier, MEd, Johns Hopkins University School of Medicine, for their invaluable comments and suggestions on earlier drafts of the manuscript.